T0	PROCESS 0 1	cranial neuropathy
T0	PROCESS 0 1	frequent objective neurological sign
T0	PROCESS 0 1	lyme neuroborreliosis
T0	PROCESS 0 1	early neurological involvement
T0	PROCESS 0 1	sensu lato
T0	PROCESS 0 1	cranial nerve
T0	PROCESS 0 1	facial nerve paresis
T0	PROCESS 0 1	common manifestation
T0	PROCESS 0 1	bilateral facial palsy
T0	PROCESS 0 1	cranial nerve affection
T0	PROCESS 0 1	previous scandinavian study
T0	PROCESS 0 1	facial palsy
T0	PROCESS 0 1	lyme disease-associated facial weakness
T0	PROCESS 0 1	painful meningoradiculoneuritis
T0	PROCESS 0 1	lyme disease
T0	PROCESS 0 1	peripheral neuropathy
T0	PROCESS 0 1	csf abnormality
T0	PROCESS 0 1	lymphocytic pleocytosis
T0	PROCESS 0 1	increased number
T0	PROCESS 0 1	plasma cell
T0	PROCESS 0 1	csf protein concentration
T0	PROCESS 0 1	blood-csf barrier damage
T0	PROCESS 0 1	intrathecal ig production
T0	PROCESS 0 1	csf glial protein marker
T0	PROCESS 0 1	glial fibrillary acidic protein
T0	PROCESS 0 1	brain parenchyma
T0	PROCESS 0 1	early lyme neuroborreliosis
